Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 9-MTH group results

Feb 13 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2025        Dec 31, 2024      Mar 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             28.39               29.28             42.10     
                 (-3.0 pct)          (-1.5 pct)        (-6.5 pct)   
  Operating       loss 4.86           loss 1.47         loss 4.00   
  Recurring       loss 5.09           loss 1.26         loss 4.40   
  Net             loss 9.62           loss 1.38         loss 9.00   
  EPS          loss 79.89 yen      loss 11.45 yen    loss 74.74 yen 
  Ann Div                             17.00 yen            NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                             17.00 yen            NIL      
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news